Ingestible Sensors Market

Ingestible Sensors Market Outlook (2022 to 2032)

The Global Ingestible Sensors Market size is projected to surpass US$ 1.7 billion by 2032. It is estimated to showcase steady growth at a CAGR of around 7.4% from 2022 to 2032. The market stood at a valuation of US$ 835.0 million in 2022.

Ingestible sensors are tools that include a wireless sensor network into a non-invasive capsule to carry out various tasks. These include obtaining information on pH levels, tension, or core body temperature.

Sensors that can be ingested might be seen as a part of the user's body and provide different chances for interaction. Simply put, these are ingestible electrical circuits of the size of a pill with a power source, microcontroller, processor, and detectors. These are made of biomaterials that allow the device to communicate and be used in the healthcare sector for illness monitoring and diagnosis.

The ingestible sensor is a vital piece of medical technology that has a positive impact on a number of clinical domains, including fitness, nutrition, and health. The industry is being primarily driven by technological improvements and rising prevalence of chronic diseases. Requirements for healthcare compliance and growing public knowledge of healthcare issues are also anticipated to promote market expansion.

Another important element driving the market is the widespread use of these products in various medical applications such as customized drug delivery. These non-invasive, user-friendly technologies support in-the-moment diagnostic and health monitoring. Increasing instances of difficulties from numerous chronic conditions brought on by individuals disregarding their prescriptions have also increased ingestible sensor demand.

The next key breakthrough in healthcare diagnosis and therapy is the ingestible sensor technology, which has been getting a lot of traction. Expanding usage of these devices in a variety of industries such as sports, physical fitness, the army, and manufacturing, is anticipated to drive growth.

Yet, there are particular issues that have been impeding the market's expansion. These include difficult technological design and identifying the patient population who might benefit from this non-invasive medical device.

How Will Sales of Ingestible Sensors between 2017 and 2021 Outpace Demand from 2022 to 2032?

As per a report by Persistence Market Research (PMR), the global ingestible sensors market share expanded exponentially in the last five years. It exhibited an astonishing CAGR of 10.4% from 2017 to 2021. It is anticipated to witness considerable growth at 7.4% CAGR in the estimated time frame.

Given that capsule endoscopes have been available on the market for about 20 years, the healthcare and medical sector is anticipated to have a high market share in 2032. In the medical field, applications for ingestible sensors include controlled drug delivery, patient monitoring, and capsule endoscopy. They improve medication adherence by alerting doctors to drug interactions and patient usage of specific medications.

Its popularity in the medical sector has grown as a result of these added benefits. Capsule endoscopy has proven to be a reliable and accurate method of endoscopic imaging. As a result, developed markets also offer compensation for capsule endoscopy operations. Ongoing expansion of capsule endoscopy is also anticipated to be fueled by rising prevalence of gastrointestinal disorders, which is driving the market.

Top Ingestible Sensors Market Trends Listed by Persistence Market Research (PMR)

• Pills known as ingestible sensors can monitor numerous bodily activities, medication usage, heart rate, and blood pressure.
• It consists of three parts: sensors, a data recorder, and software.
• With the aid of these ingestible sensors, patients can get real-time information and address unresolved problems that sometimes go unanswered by doctors.
• Demand for ingestible sensors has been growing rapidly in recent years.
• There are several factors influencing the demand for ingestible sensors, one of which is the rising prevalence of chronic diseases.
• These include diabetes, cardiovascular disease, and cancer.
• These sensors can help patients monitor their conditions effectively and provide real-time data to healthcare providers.
• Chronic diseases such as diabetes have been growing rapidly in recent years.
• There were around 537 million adults suffering from diabetes in 2021.
• It is projected that the number of people suffering from diabetes will reach 643 million adults by 2030.
• There were around 6.7 million deaths directly attributed to diabetes in 2021.
• Ingestible sensors can help healthcare providers and patients monitor their conditions in real-time.
• Rising cases of chronic illnesses such as diabetes in the world is set to push demand for ingestible sensors.
• There is also an increasing focus on preventive healthcare, which is fueling the demand for technologies that can help prevent diseases before they occur.
• Ingestible sensors can help individuals monitor their health and identify potential health issues before they become more serious.
• With rising awareness about chronic diseases and increasing trend of healthy lifestyles, millennials are willing to take the steps necessary to prevent diseases.
• Ingestible sensors can be utilized to monitor various factors within the body and provide real-time data.

Which Region is Projected to Offer Significant Opportunities to Ingestible Sensors Manufacturers?

North America ingestible sensors market size was US$ 311.9 million in 2021. It is estimated to reach a valuation of US$ 344.0 million in 2022.

North America is projected to cross a value of US$ 700.4 million in 2032. The region is likely to exhibit a CAGR of 41.2% from 2022 to 2032.

North America has a significant number of adults suffering from diabetes with around 1 in 4 adults suffering from the disease in 2021. That amounts to around 51 million adults suffering from diabetes in 2021.

It is projected that by 2030, the number of adults suffering from diabetes will increase to around 57 million. Diabetes also claimed around 931,000 lives in the region in 2021. It further resulted in healthcare costs of around US$ 415 billion spent on treatment, thereby making it one of the significant expenditures for residents in the country.

With rising prevalence of diabetes in the country, patients and healthcare providers are looking for better treatment and monitoring options that are accurate and cost-effective. Ingestible sensor sales are projected to increase as these can provide real-time data to healthcare providers about patients, thereby improving diagnosis. Doctors can also monitor the patient remotely, further eliminating the need for an in-person visit and reducing the costs for patients.

Country-wise Insights:

Why is the Demand for Ingestible Sensors and Smart Pills Surging in the United States of America?

The United States of America ingestible sensors market is expected to be worth US$ 546.3 million by 2032. It is anticipated to create an absolute dollar growth of US$ 247.7 million till 2032.

The United States of America market witnessed growth at a CAGR of 8.9% from 2017 to 2021. It is estimated to fuel at a CAGR of 6.2% from 2022 to 2032.

The United States of America has a significant population suffering from chronic diseases such as diabetes. In 2022, the number of Americans suffering from diabetes was around 37.3 million. It was about 11.7% of the population.

It is predicted that by 2030, the number of people suffering from diabetes would reach 54.9 million in the country. Ingestible sensors can be used to monitor various factors within the body and provide real-time data. Hence, their demand is projected to increase therefore in the United States of America.

Would the United Kingdom Showcase High Need for Ingestible Sensor Technology?

The United Kingdom ingestible sensors market is set to exceed US$ 82.1 billion by 2032. It is projected to create an absolute dollar opportunity of US$ 38.5 billion from 2022 to 2032.

The United Kingdom exhibited steady growth at a CAGR of 9.2% from 2017 to 2021. It is expected to flourish at a CAGR of 6.5% in the assessment period.

Around 4.8 million people were suffering from diabetes in 2019. It is projected that by 2025, the number of people suffering from diabetes will reach around 5.3 million in the country. Ingestible sensors can be used for patient monitoring and providing accurate data, which would propel their demand.

Would China be a Reputed Ingestible Pill Sensor Manufacturing Hub by 2032?

China ingestible sensors market is likely to surge at US$ 147.3 million by 2032. It is predicted to create an incremental opportunity of US$ 81.3 million in the next ten years.

China market showcased decent growth at a CAGR of 12.0% from 2017 to 2021. It is estimated to elevate at a CAGR of 8.4% from 2022 to 2032.

China is a predominant country in terms of the prevalence of diabetes in the world. Around 141 million adults were suffering from diabetes in the country. It is projected that the number of people suffering from diabetes would increase to around 435 million adults by 2030.

Ingestible sensors can be used for better monitoring of diabetes patients. Hence, rising incidence of diabetes in China is projected to propel their demand during the assessment period.

Category-wise Insights

Which is the Most Used Medical Body Sensors across the Globe?

The temperature sensor segment is projected to witness significant growth in the forecast period. It showcased growth at a CAGR of 10.0% from 2017 to 2021. It is expected to escalate at a CAGR of 7.3% from 2022 to 2032.

To measure the temperature of body fluids such as the stomach and intestines, temperature sensors are frequently used in ingestible sensors. Changes in body temperature can be an indicator of the presence of certain diseases or conditions. Hence, temperature data can offer important information about a person's health status.

Temperature sensors used in ingestible devices must be small, durable, and able to withstand harsh conditions inside the body such as the acidic environment of the stomach. They must also be accurate and sensitive enough to detect small changes in temperature.

Temperature sensors are an important component of ingestible sensors, as they can provide valuable insights into a person's health. They can also help healthcare providers make more informed decisions about treatment and management of various conditions.

Which Vertical is the Dominant User of Ingestible Pill Sensors Globally?

Ingestible sensors used in the medical industry are projected to witness prominent growth through 2032. It exhibited moderate growth at a CAGR of 9.6% from 2017 to 20221. It is expected to bolster at a CAGR of 7.2% from 2022 to 2032.

Ingestible sensors are a type of digital health technology that can be swallowed similar to a pill. These are used to monitor various aspects of a person's health from inside the body.

In the medical industry, ingestible sensors are being used for a wide range of applications. These include medication adherence monitoring where these sensors can be used to track when a patient takes their medication, helping healthcare providers ensure that they are taking it as prescribed. Ingestible sensors can be used to monitor pH levels and temperature in the gastrointestinal tract. It helps to provide valuable information about conditions such as acid reflux, gastroesophageal reflux disease, and inflammatory bowel disease.

Competitive Landscape

There are a few key participants in the highly competitive ingestible sensors industry. Several of these large-scale businesses nowadays control the market in regard to share.

Similar product prototypes are being offered at reduced prices by new competitors in this sector, which could impact already-established businesses. Most businesses use mergers and acquisitions (M&A) and collaborations to capture the most prominent portion of the market.

A few recent developments in the ingestible sensors market are:

• In October 2021, in order to speed up the production of game-changing products and solutions, Phillips-Medisize and MedTech Devices disclosed growth of their global manufacturing footprint. The business's global footprint currently includes 36 top-notch factories with expandable, end-to-end capabilities. These are mainly designed to assist clients in bringing ground-breaking innovations to market swiftly and successfully from any location in the world.
• In March 2019, the PowerSpiral endoscopic equipment was made available throughout Europe and specific parts of Asia-Pacific, according to a statement from Olympus Corporation. After approvals are accepted, PowerSpiral will debut in the United States of America and other countries in Asia Pacific. The tool can be inserted completely into the small intestine by using a spinning mechanical attachment that is attached to the scope.

Scope of the Report

Ingestible Sensors Market Outlook by Category:

By Component:

• Sensor
• Wearable Patch
• Software

By Sensor Type:

• Temperature Sensor
• Pressure Sensor
• pH Sensor
• Image Sensor

By Vertical:

• Medical
• Sports and Fitness

By Region:

• North America
• Latin America
• Europe
• Asia Pacific
• Middle East and Africa

To know more about delivery timeline for this report Contact Sales